Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF JUNE 30, 2023 SAM #7885
SOLICITATION NOTICE

Q -- Acquisition of Services Related to Compound 21 and In Vivo Pharmacokinetics Studies

Notice Date
6/28/2023 3:18:27 PM
 
Notice Type
Presolicitation
 
NAICS
541380 — Testing Laboratories
 
Contracting Office
NATIONAL INSTITUTES OF HEALTH NICHD BETHESDA MD 20817 USA
 
ZIP Code
20817
 
Solicitation Number
NICHD-23-231
 
Response Due
7/10/2023 6:00:00 AM
 
Archive Date
07/25/2023
 
Point of Contact
Amber Harris
 
E-Mail Address
amber.harris@nih.gov
(amber.harris@nih.gov)
 
Description
The objective of the research is to advance the testing of compound 21 to determine its ability to become a new treatment for HIV infection. To properly make the molecule for this work, the lab must have the molecule synthesis in sufficient quantities to test in animals. Using the procedures provided by the NIDDK chemists, the company must scale up the production of compound 21 and deliver 10 g to the NIDDK lab. The compound 21 produced must also be tested for pharmacokinetics in rats and mice, and its metabolism studied. Results from each set of tests done are added to the file that will eventually be submitted for FDA approval as an investigational new drug.� The continuity of the project is enhanced using as few CRO�s as possible and only ones technically qualified to meet the specific needs of the research.
 
Web Link
SAM.gov Permalink
(https://sam.gov/opp/c91387e542fd4235a52c87d16a57f83e/view)
 
Place of Performance
Address: Bethesda, MD 20892, USA
Zip Code: 20892
Country: USA
 
Record
SN06730594-F 20230630/230629060346 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.